Real-World Effectiveness of Racotumomab as Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients

Background: Advanced non-small cell lung cancer (NSCLC) has limited curative options and poor survival. Racotumomab, an anti-idiotype monoclonal antibody vaccine targeting tumor gangliosides, has shown efficacy in clinical trials. This study evaluated its real-world effectiveness as maintenance ther...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sailyn Alfonso Alemán, Haslen Cáceres Lavernia, Kirenia Camacho Sosa, Soraida C. Acosta Brooks, Orestes Santos Morales, Carmen E. Viada González, Meylán Cepeda Portales, Mayelín Troche Concepción, Loipa Medel Pérez, Leticia Cabrera Benítez, Milagros C. Domecq Salmón, Daymys Estévez Iglesias, Mayra Ramos Suzarte, Tania Crombet Ramos
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-10-01
Col·lecció:	Vaccines
Matèries:	anti-idiotypic vaccine racotumomab NSCLC cancer vaccine real world data
Accés en línia:	https://www.mdpi.com/2076-393X/13/10/1035
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!